Molecular Insight Pharmaceuticals, a developer of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics, registered for an initial public offering today. Piper Jaffray and SG Cowen are the joint book runners on the deal. Neither terms nor timing have been made available.
